China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China · Delayed Price · Currency is CNY 14.94
+0.60 (4.18%)
Sep 30, 2026, 3:04 PM CST
SHE:300294 Market Cap
SHE:300294 has a market cap or net worth of 7.53 billion as of October 2, 2026. Its market cap has decreased by -39.39% in one year.
Market Cap
7.53B
Enterprise Value
4.78B
Revenue
1.69B
Ranking
n/a
PE Ratio
n/a
Stock Price
14.94
ChartMarket Cap Chart
Since March 8, 2012, SHE:300294's market cap has increased from 2.94B to 7.53B, an increase of 156.15%. That is a compound annual growth rate of 6.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 7.53B | -33.89% |
| Dec 31, 2025 | 11.40B | -25.36% |
| Dec 31, 2024 | 15.27B | -10.10% |
| Dec 29, 2023 | 16.98B | -7.88% |
| Dec 30, 2022 | 18.44B | -4.67% |
| Dec 31, 2021 | 19.34B | 35.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Liaoning Chengda Biotechnology | 8.64B |
| Beijing Hotgen Biotech | 8.33B |
| Aurisco Pharmaceutical | 8.10B |
| Daan Gene | 8.07B |
| Novogene | 8.01B |
| Innovita Biological Technology | 7.33B |
| Chengdu Kanghua Biological Products | 7.32B |
| Jiangsu Aidea Pharmaceutical Group | 7.00B |